Dataset Information


Anti-?-enolase is a prognostic marker in postoperative lung cancer patients.

ABSTRACT: Our previous studies suggest that antibodies against ENO1 (anti-ENO1 Ab) have a protective role in patients with non-small cell lung carcinoma. In this study, we evaluated the prognostic value of anti-ENO1 Ab levels in non-small cell lung carcinoma patients undergoing surgery. Circulating levels of anti-ENO1 Ab were assessed in 85 non-small cell lung carcinoma patients before and after surgery, and were correlated with clinical outcome. After surgery, patients with a higher increase of anti-ENO1 Ab had a lower hazard ratio and a better progression-free survival. Using animal models, we demonstrated that tumor cells reduce the circulating levels of anti-ENO1 Ab through physical absorption and neutralization of anti-ENO1 Ab with surface-expressed and secreted ENO1, respectively. Mice transplanted with ENO1-overexpressing tumors generated ENO1-specific regulatory T cells to suppress the production of anti-ENO1 Ab. Our results suggest that the increase of anti-ENO1 Ab may reflect anti-tumor immune responses and serve as a prognostic marker in postoperative lung cancer patients.


PROVIDER: S-EPMC4741510 | BioStudies | 2015-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4484442 | BioStudies
2020-01-01 | S-EPMC7132141 | BioStudies
2019-01-01 | S-EPMC6896005 | BioStudies
1000-01-01 | S-EPMC6245378 | BioStudies
2016-01-01 | S-EPMC5073284 | BioStudies
1000-01-01 | S-EPMC4910736 | BioStudies
2019-01-01 | S-EPMC6683135 | BioStudies
2019-01-01 | S-EPMC6407000 | BioStudies
2020-01-01 | S-EPMC7061435 | BioStudies
1000-01-01 | S-EPMC4072724 | BioStudies